Anti-HIV antibody and drug combinations exhibit synergistic activity against drug-resistant HIV-1 strains

- Combining anti-HIV antibody and drugs showed synergistic anti-HIV-1 activity.
- Anti-HIV antibody/drug combinations are effective against drug-resistant mutants.
- Combining drugs with different targets increase drug-resistance barrier.
- Drug combinations lead to dose-reduction, thus reducing drugs' cost and toxicity.